Skip to main content

Tower Research Capital LLC (TRC)

Position in BTAI — BioXcel Therapeutics, Inc.

CIK 1533421 NEW YORK, NY

Position in BTAI

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$320
-$1,982 QoQ
Shares Held
227
-86.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#34
of 47 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BTAI Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Tower Research Capital LLC (TRC) holds $14,082,412 across 58 Drug Manufacturers - Specialty & Generic names. BTAI ranks #56 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in BTAI

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $320 227
2026-03-31 $2,302 1,718
2025-09-30 $10,068 3,933
2025-06-30 $2,479 1,370
2025-03-31 $308 152
2024-12-31 $96 259
2024-09-30 $6,709 10,999
2024-06-30 $15,452 12,072
2024-03-31 $13,048 4,627
2023-12-31 $40,804 13,832
2023-09-30 $10,316 4,078
2023-06-30 $37,821 5,679
2023-03-31 $28,530 1,529
2022-12-31 $8,079 501
2022-09-30 $14,775 1,250
2022-06-30 $34,689 2,628
2022-03-31 $69,358 3,317
2021-12-31 $95,347 4,690
2021-09-30 $142,219 4,686
2021-06-30 $23,683 815
2021-03-31 $74,062 1,716
2020-12-31 $4,065 88
2020-09-30 $76,747 1,770
2020-06-30 $316,098 5,963
2020-03-31 $2,659 119